This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (190)
Death (61)
Life Threatening Events (17)
Disability (1)
Reports by Reaction Type
Pyrexia (24),
Death (22),
Cytomegalovirus Infection (15),
Pancytopenia (13),
C-Reactive Protein Increased (12),
Adenovirus Infection (12),
Pneumonia (12),
Dyspnoea (12),
Infection (11),
Pleural Effusion (11),
Bronchopulmonary Aspergillosis (9),
Fall (8)
Below are a few examples of reports where side effects / adverse reactions may be related to Campath (Alemtuzumab). For a complete list or a specific selection of reports, please use the links above.
Possible Campath side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 42 year old male
Reactions: Off Label Use, Fatigue, Malaise, Chest Pain, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Other drugs received by patient: Mycophenolate Mefetil; Cyclosporine; Prednisone TAB
Possible Campath side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 92.8 kg (204.2 pounds)
Reactions: Tachyarrhythmia, Atrial Fibrillation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-07-21
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-07-12
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2010-07-21
Other drugs received by patient: Certoparin Sodium; Marcumar; Digoxin; Metoprolol Tartrate; Candesartan Cilexetil; Acyclovir; Levothyroxine Sodium; Pantoprazole; Prednisolone; Tamsulosin HCL; Torsemide
Possible Campath side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-23
Patient: 60 year old female
Reactions: Endophthalmitis, Bronchopulmonary Aspergillosis, Cerebral Artery Embolism, Fungal Endocarditis, Pancytopenia, Infection in AN Immunocompromised Host
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Fludara
Indication: Chronic Lymphocytic Leukaemia
Mycophenolate Mofetil
Indication: Graft Versus Host Disease
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: male
Reactions: Phlebitis, Lymphocyte Percentage Decreased, Hydronephrosis, Arterial Thrombosis Limb, Urinary Tract Infection, Cystitis Noninfective, Human Polyomavirus Infection, Prothrombin Time Prolonged, Urethritis, Blood Fibrinogen Increased, Genitourinary Tract Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, first 3 days of each cycle (6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Bactrim; Valganciclovir; Vfend; Folic Acid
Possible Campath side effects in male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend
Possible Campath side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir
Possible Campath side effects in 45 year old female
Reported by a physician from United States on 2012-08-21
Patient: 45 year old female
Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-06-01
Cisplatin
Dosage: unk
Indication: Mycosis Fungoides
Cyclophosphamide
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Daunorubicin HCL
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Dexamethasone
Dosage: unk
Indication: Mycosis Fungoides
Etoposide
Dosage: unk
Indication: Mycosis Fungoides
Fludara
Dosage: 2 cycles
Indication: Mycosis Fungoides
Ifosfamide
Dosage: unk
Indication: Mycosis Fungoides
Prednisone
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Vincristine
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Possible Campath side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: 51 year old female
Reactions: Nausea, Diarrhoea, Clostridium Difficile Colitis, Microangiopathic Haemolytic Anaemia, Muscular Weakness, Renal Failure Acute, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Start date: 2012-05-01
Campath
Dosage: 100 mg, unknown/d
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-23
Fludarabine Phosphate
Dosage: 355 mg, total dose
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-23
Fludarabine Phosphate
Dosage: unk
Start date: 2012-05-01
Melphalan Hydrochloride
Dosage: 333 mg, total dose
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-23
Melphalan Hydrochloride
Dosage: unk
Start date: 2012-05-02
Prograf
Dosage: unk
Indication: Product Used FOR Unknown Indication
Sprycel
Dosage: unk
Administration route: Oral
Start date: 2012-04-26
Sprycel
Dosage: unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-23
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male
Reactions: Hydronephrosis, Urinary Tract Infection, Cystitis Noninfective, Urethritis, Human Polyomavirus Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Bactrim; Vfend; Valganciclovir; Folic Acid
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Cystitis Haemorrhagic, Adenovirus Infection, Human Polyomavirus Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Vfend; Bactrim; Valganciclovir; Folic Acid
Possible Campath side effects in male
Reported by a consumer/non-health professional from France on 2012-08-17
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Prostatitis, Adenovirus Infection, Dysuria, Cystitis Haemorrhagic, Pollakiuria, Human Polyomavirus Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Vfend; Folic Acid; Bactrim
Possible Campath side effects in 74 year old female
Reported by a physician from United States on 2012-08-16
Patient: 74 year old female, weighing 75.9 kg (167.0 pounds)
Reactions: Blood Culture Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 2000mg cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-06-19
Campath
Dosage: 30mg weekly
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-06-05
Other drugs received by patient: Mirtazapine; Esomeprazole Magnesium; Humalog; Prochlorperazine; Alprazolam; Fluconazole; Rosuvastatin; Ramipril; Pentamidine Isethionate; Estradiol; Nepafenac; Ferrous Sulfate TAB; Pred Forte; Lantus; Acyclovir; Cyanocobalamin + Folic Acid + Pyridoxine Hydrochloride; Vesicare
Possible Campath side effects in 3 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 3 year old male
Reactions: Adenovirus Infection, Respiratory Distress
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Cord Blood Transplant Therapy
Fludara
Dosage: unk
Indication: Cord Blood Transplant Therapy
Melphalan Hydrochloride
Dosage: unk
Indication: Cord Blood Transplant Therapy
Possible Campath side effects in 13 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 13 year old female
Reactions: Diarrhoea, Adenovirus Infection
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Fludara
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Melphalan Hydrochloride
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Possible Campath side effects in female
Reported by a physician from United States on 2012-08-09
Patient: female
Reactions: Off Label Use, Autoimmune Neutropenia
Drug(s) suspected as cause:
Campath
Possible Campath side effects in female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-08-09
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Lymphocyte Count Increased, Dyspnoea, Vomiting, Nausea, Graft Dysfunction, Tachycardia, Hyperhidrosis, Pallor, Convulsion, Tremor, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, unk
Indication: Transplant Rejection
Start date: 2012-07-29
Campath
Dosage: unk
Other drugs received by patient: Hydrocortisone; Dithiaden; Paralen; Solu-Medrol; Immune Globulin NOS; Dithiaden
Possible Campath side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-06
Patient: 60 year old female
Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Corticosteroid NOS
Dosage: unk
Indication: Graft Versus Host Disease
Cyclophosphamide
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Fludara
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Mycophenolate Mofetil
Dosage: unk
Indication: Graft Versus Host Disease
Possible Campath side effects in 54 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-23
Patient: 54 year old male
Reactions: Abdominal Pain, Small Intestine Ulcer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 1xper cycle for 71 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-05-09
Cyclophosphamide
Dosage: 1520 mg, unk, 1x per cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-13
Doxorubicin Hydrochloride
Dosage: 102 mg, unk, 1x per cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-13
Pegfilgrastim
Dosage: 6 mg, unk, 1xper cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-03-03
End date: 2012-06-16
Prednisone
Dosage: 100 mg, unk,5xper cycle for 110 days
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-17
Vincristine
Dosage: 2 mg, unk, 1x per cycle for 36 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-04-04
Possible Campath side effects in male
Reported by a pharmacist from United States on 2012-07-23
Patient: male, weighing 55.3 kg (121.7 pounds)
Reactions: Atelectasis, Renal Haemorrhage, Hydronephrosis, Subcutaneous Emphysema, Ascites, Cholelithiasis, Off Label Use, Haemoglobin Decreased, Haematocrit Decreased, Pleural Effusion, Thrombocytopenia, Incision Site Haemorrhage
Drug(s) suspected as cause:
Berinert
Dosage: 1100 units ivp over 6 min via syringe pump),
Indication: Transplant Rejection
Start date: 2012-06-16
Berinert
Dosage: 1100 units ivp over 6 min via syringe pump),
Indication: Transplant Rejection
Start date: 2012-06-18
Campath
Dosage: 30 mg x 1 pdo#0 subcutaneous
Indication: Premedication
Cellcept
Dosage: 500 mg bid, oral
Administration route: Oral
Other drugs received by patient: Prograf; Prednisone; Ganciclovir
Possible Campath side effects in female
Reported by a lawyer from United States on 2012-07-20
Patient: female
Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Campath
End date: 2004-09-27
Thalidomide
Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid
Possible Campath side effects in 82 year old female
Reported by a consumer/non-health professional from United States on 2012-07-19
Patient: 82 year old female, weighing 45.1 kg (99.2 pounds)
Reactions: Hemiparesis, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: cycle 2: on days 1, 3, 5, 8, 10, 13, 15, 17, 19, 22, 24, 26
Start date: 2012-01-01
End date: 2012-01-01
Campath
Dosage: 3 mg, cycle 1: day 1
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-01
End date: 2012-01-01
Campath
Dosage: 30 mg, cycle 1: day 3
Start date: 2012-01-01
End date: 2012-01-01
Campath
Dosage: 10 mg, cycle 1: day 2
Start date: 2012-01-01
End date: 2012-01-01
Campath
Dosage: cycle 1: on days 6, 8, 10, 13, 15, 17, 20, 22, 24, 27, 29, 31
Start date: 2012-01-01
End date: 2012-01-01
Rituximab
Dosage: 375 mg/m2, on days 8, 15, 22, 29 of cycle 1
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-01
End date: 2012-01-01
Rituximab
Dosage: 375 mg/m2, on days 3, 10, 17, 24 of cycle 2
Start date: 2012-01-01
End date: 2012-01-01
Possible Campath side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-17
Patient: female, weighing 45.1 kg (99.2 pounds)
Reactions: Hemiparesis, Progressive Multifocal Leukoencephalopathy
Drug(s) suspected as cause:
Campath
Dosage: 360 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 2040 mg
Possible Campath side effects in 33 year old female
Reported by a physician from United States on 2012-07-13
Patient: 33 year old female
Reactions: Enterococcal Bacteraemia, Retinal Haemorrhage, Graft Versus Host Disease, Pulmonary Alveolar Haemorrhage, Microsporidia Infection, Retinal Disorder, Meningitis, Hydrocephalus
Adverse event resulted in: death
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Prophylaxis Against Graft Versus Host Disease
Thymoglobulin
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Other drugs received by patient: Cyclophosphamide; Cyclosporine; Fludarabine Phosphate
Possible Campath side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-13
Patient: 61 year old male
Reactions: Candida Pneumonia, Bronchopneumonia, Febrile Neutropenia, Respiratory Distress, Organising Pneumonia, Respiratory Failure, Interstitial Lung Disease, Pseudomonal Sepsis, Opportunistic Infection, Stenotrophomonas Sepsis, Tracheitis, Septic Shock, Sinusitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Cyclophosphamide
Dosage: 690 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 46 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Pegfilgrastim
Dosage: 6 mg, qd
Start date: 2010-03-01
End date: 2010-03-01
Pegfilgrastim
Dosage: 3 mg, qd
Indication: T-Cell Lymphoma
Posaconazole
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-11
Vincristine
Dosage: 2 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Vincristine
Dosage: 2 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Possible Campath side effects in 54 year old male
Reported by a physician from Germany on 2012-07-13
Patient: 54 year old male
Reactions: Abdominal Pain, Small Intestine Ulcer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 1xper cycle for 71 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-05-09
Cyclophosphamide
Dosage: 1520 mg, unk, 1x per cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-13
Doxorubicin HCL
Dosage: 102 mg, unk, 1x per cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-13
Pegfilgrastim
Dosage: 6 mg, unk, 1xper cycle for 106 days
Indication: T-Cell Lymphoma
Start date: 2012-03-03
End date: 2012-06-16
Prednisone
Dosage: 100 mg, unk,5xper cycle for 110 days
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-06-17
Vincristine
Dosage: 2 mg, unk, 1x per cycle for 36 days
Indication: T-Cell Lymphoma
Start date: 2012-02-29
End date: 2012-04-04
Possible Campath side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-10
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Candida Pneumonia, Bronchopneumonia, Tachycardia, Atrial Fibrillation, Febrile Neutropenia, General Physical Health Deterioration, Lactic Acidosis, Respiratory Distress, Respiratory Failure, Skin Lesion, Pseudomonal Sepsis, Tracheitis, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 690 mg, once
Start date: 2010-02-22
End date: 2010-02-22
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 46 mg, once
Start date: 2010-02-22
End date: 2010-02-22
Pegfilgrastim
Dosage: 6 mg, once
Start date: 2010-03-01
End date: 2010-03-01
Pegfilgrastim
Dosage: 3 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-11
Prednisone
Dosage: 100 mg, qdx5
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Vasopressin
Dosage: unk
Indication: Blood Pressure Management
Vincristine
Dosage: 2 mg, qd
Start date: 2010-02-22
End date: 2010-02-22
Vincristine
Dosage: 2 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Other drugs received by patient: Zienam; Posaconazole; Taranic; Zienam; Taranic; Candiohermal; Candiohermal
Possible Campath side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-10
Patient: 61 year old male
Reactions: Respiratory Failure, Bronchopneumonia, Pseudomonal Sepsis, Febrile Neutropenia, Septic Shock, Tracheitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Cyclophosphamide
Dosage: 690 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 46 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Pegfilgrastim
Dosage: 3 mg, qd
Indication: T-Cell Lymphoma
Pegfilgrastim
Dosage: 6 mg, qd
Start date: 2010-03-01
End date: 2010-03-01
Posaconazole
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-11
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Vincristine
Dosage: 2 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Vincristine
Dosage: 2 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Possible Campath side effects in 62 year old male
Reported by a consumer/non-health professional from Netherlands on 2012-07-06
Patient: 62 year old male
Reactions: Viral Test Positive, Renal Failure, Adenovirus Infection, Hepatic Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Campath
Dosage: dose escalation via 10 / 20 / 30 mg per day on 3 consecutive days in cycle 1
Indication: T-Cell Lymphoma
Start date: 2009-11-05
Campath
Dosage: a-chop-14, treatment days 1 and 2 in cycles 2 to 6 every 2 weeks
Start date: 2009-11-06
End date: 2009-12-30
Cyclophosphamide
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Doxorubicin HCL
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Pegfilgrastim
Indication: Prophylaxis
Pegfilgrastim
Dosage: a-chop-14, on treatment day 4 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-08
End date: 2009-12-30
Prednisone TAB
Dosage: a-chop-14, treatment days 1-5 per cycle every 2 weeks
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Vincristine
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Other drugs received by patient: Trimethoprim / Sulfamethoxazol; Valaciclovir; Prednisone TAB; Fluconazole
Possible Campath side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-06
Patient: 62 year old male
Reactions: Viral Test Positive, Renal Failure, Adenovirus Infection, Hepatic Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Campath
Dosage: a-chop-14, treatment days 1 and 2 in cycles 2 to 6 every 2 weeks
Start date: 2009-11-06
End date: 2009-12-30
Campath
Dosage: dose escalation via 10 / 20 / 30 mg per day on 3 consecutive days in cycle 1
Indication: T-Cell Lymphoma
Start date: 2009-11-05
Cyclophosphamide
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Doxorubicin HCL
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Pegfilgrastim
Dosage: a-chop-14, on treatment day 4 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-08
End date: 2009-12-30
Pegfilgrastim
Indication: Prophylaxis
Prednisone TAB
Dosage: a-chop-14, treatment days 1-5 per cycle every 2 weeks
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Vincristine
Dosage: a-chop-14, treatment day 1 per cycle
Indication: T-Cell Lymphoma
Start date: 2009-11-05
End date: 2009-12-30
Other drugs received by patient: Fluconazole; Valaciclovir; Prednisone TAB; Trimethoprim / Sulfamethoxazol
Possible Campath side effects in 73 year old male
Reported by a physician from Germany on 2012-07-06
Patient: 73 year old male
Reactions: Stenotrophomonas Infection, Febrile Neutropenia, Atrial Fibrillation, Ileus Paralytic, Multi-Organ Failure, Pneumonia Bacterial, Respiratory Failure, Cardiac Failure, Oesophagitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, q2w
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-04
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-03
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-03
Pegfilgrastim
Dosage: 6 mg, q2w
Indication: T-Cell Lymphoma
Start date: 2009-06-29
End date: 2009-09-06
Pegfilgrastim
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-06-17
End date: 2009-09-10
Vincristine
Dosage: 1 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-17
End date: 2009-09-03
Other drugs received by patient: Ciprofloxacin
|